Eli Lilly to buy Loxo Oncology for $8 billion in huge bet on cancer genetics

Eli Lilly to buy Loxo Oncology for $8 billion in huge bet on cancer genetics

By MATTHEW HERPER

ANNE WESTON/FRANCIS CRICK INSTITUTE

The pharmaceutical giant will purchase Loxo Oncology, a tiny startup, for $8 billion in cash to gain access to the company’s cancer medicines.

READ MORE